Anti-HIV-1 antibody-dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum IgG. (Q39325821)

11 September 2017

Anti-HIV-1 antibody-dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum IgG. (English)

1 reference

11 September 2017

0 references

0 references

9

1 reference

11 September 2017

7

Rob J Center

1 reference

11 September 2017

8

Anthony Jaworowski

1 reference

11 September 2017

Marit Kramski

1

1 reference

11 September 2017

Gregor F Lichtfuss

2

1 reference

11 September 2017

Marjon Navis

3

1 reference

11 September 2017

Gamze Isitman

4

1 reference

11 September 2017

Leia Wren

5

1 reference

11 September 2017

Grant Rawlin

6

1 reference

11 September 2017

Damian F J Purcell

10

1 reference

11 September 2017

language of work or name

English

0 references

publication date

28 August 2012

1 reference

European Journal of Immunology

11 September 2017

1 reference

11 September 2017

42

1 reference

11 September 2017

10

1 reference

11 September 2017

2771-2781

1 reference

Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface

11 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

Antibody epitope exposure and neutralization of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Humoral immune responses to microbial infections in the genital tract

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcγ receptors to define the role of effector functions in protection against HIV.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Activation of NK cells by ADCC antibodies and HIV disease progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Fc receptor but not complement binding is important in antibody protection against HIV.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Immune components of bovine colostrum and milk

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Bovine colostrum as a biologic in clinical medicine: a review--Part II: clinical studies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Hyperimmune bovine colostrum as a low-cost, large-scale source of antibodies with broad neutralizing activity for HIV-1 envelope with potential use in microbicides.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

A New Set of Monoclonal Antibodies Against Human FcγRII (CD32) and FcγRIII (CD16): Characterization and Use in Various Assays

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity (ADCC).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Fc receptors and immunoglobulin binding factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Molecular basis of Fc receptor function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Prevention and treatment of influenza with hyperimmune bovine colostrum antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242469

7 January 2021

Identifiers

DOI

10.1002/EJI.201242469

1 reference

11 September 2017

1 reference